Development of a tryptophan metabolomics-based diagnostic model for hepatic encephalopathy in liver cirrhosis. [PDF]
Cao X, Wang L, Ning L, Hu Y, Fu N.
europepmc +1 more source
Diabetes and liver cirrhosis: shared pathways and clinical implications - a narrative review. [PDF]
Mohan A +12 more
europepmc +1 more source
Low-Dose vs. Standard Care Iv Human Albumin During Large-Volume Paracentesis in Patients With Liver Cirrhosis: A Systematic Review. [PDF]
Bot KKIM +3 more
europepmc +1 more source
Comprehensive Pathophysiology Repository for PBPK Modeling in Liver Cirrhosis: Quantifying Continuous Disease Progression and Population Variability. [PDF]
Schneider ARP +3 more
europepmc +1 more source
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert Panel. [PDF]
Karsten Dafonte K +15 more
europepmc +1 more source
Systemic hematologic, metabolic, and inflammatory dysregulation in liver cirrhosis and hepatocellular carcinoma: diagnostic utility of novel indices in an Egyptian cohort. [PDF]
Sherief DE +6 more
europepmc +1 more source
Related searches:
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C infection, autoimmune diseases, cholestatic diseases, and iron or copper overload.
Ginès, Pere +5 more
openaire +5 more sources
Cirrhosis is an increasing cause of morbidity and mortality in more developed countries, being the 14th most common cause of death worldwide but fourth in central Europe. Increasingly, cirrhosis has been seen to be not a single disease entity, but one that can be subclassified into distinct clinical prognostic stages, with 1-year mortality ranging from
Emmanuel A, Tsochatzis +2 more
openaire +4 more sources

